CVS Health Corporation (CVS) Stake Maintained by Private Capital Advisors Inc.
Private Capital Advisors Inc. continued to hold its stake in shares of CVS Health Corporation (NYSE:CVS) during the second quarter, Holdings Channel reports. The firm owned 8,450 shares of the pharmacy operator’s stock at the end of the second quarter. Private Capital Advisors Inc.’s holdings in CVS Health Corporation were worth $809,000 as of its most recent filing with the SEC.
A number of other large investors also recently modified their holdings of CVS. Nordea Investment Management AB increased its stake in shares of CVS Health Corporation by 61.3% in the second quarter. Nordea Investment Management AB now owns 11,644,431 shares of the pharmacy operator’s stock worth $1,114,838,000 after buying an additional 4,423,216 shares in the last quarter. Credit Agricole S A increased its stake in shares of CVS Health Corporation by 112.8% in the first quarter. Credit Agricole S A now owns 2,492,231 shares of the pharmacy operator’s stock worth $258,521,000 after buying an additional 1,320,987 shares in the last quarter. NN Investment Partners Holdings N.V. acquired a new stake in shares of CVS Health Corporation during the first quarter worth $125,795,000. State Street Corp increased its stake in shares of CVS Health Corporation by 2.4% in the first quarter. State Street Corp now owns 44,552,112 shares of the pharmacy operator’s stock worth $4,621,391,000 after buying an additional 1,023,799 shares in the last quarter. Finally, Investec Asset Management LTD increased its stake in shares of CVS Health Corporation by 66.4% in the first quarter. Investec Asset Management LTD now owns 2,157,210 shares of the pharmacy operator’s stock worth $223,767,000 after buying an additional 860,894 shares in the last quarter. 81.08% of the stock is currently owned by institutional investors and hedge funds.
CVS Health Corporation (NYSE:CVS) traded down 0.03% during trading on Friday, reaching $90.12. The company’s stock had a trading volume of 6,406,845 shares. CVS Health Corporation has a one year low of $86.50 and a one year high of $106.67. The firm has a market cap of $96.09 billion, a PE ratio of 20.73 and a beta of 0.84. The company has a 50-day moving average of $95.13 and a 200 day moving average of $98.29.
CVS Health Corporation (NYSE:CVS) last posted its quarterly earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.02. The business earned $43.70 billion during the quarter, compared to the consensus estimate of $44.28 billion. CVS Health Corporation had a net margin of 2.88% and a return on equity of 15.86%. The firm’s revenue for the quarter was up 17.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.19 earnings per share. Analysts expect that CVS Health Corporation will post $5.86 EPS for the current fiscal year.
A number of equities research analysts have weighed in on CVS shares. Credit Suisse Group AG reaffirmed a “buy” rating and issued a $115.00 target price on shares of CVS Health Corporation in a report on Sunday, June 5th. Leerink Swann reaffirmed a “buy” rating on shares of CVS Health Corporation in a report on Friday, June 10th. Morgan Stanley downgraded CVS Health Corporation from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $111.00 to $104.00 in a report on Monday, June 20th. Deutsche Bank AG raised their target price on CVS Health Corporation from $99.00 to $105.00 and gave the company a “hold” rating in a report on Wednesday, June 22nd. Finally, Mizuho reaffirmed a “buy” rating and issued a $108.00 target price (down previously from $117.00) on shares of CVS Health Corporation in a report on Thursday, June 23rd. Six equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus price target of $113.02.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.